Ramsay Santé
Sophie Lacoste currently serves as Responsable d'Applications Achats et Pharmacie at Ramsay Santé since February 2021. Previously, from February 2001 to October 2020, Sophie held several key roles at LA HALLE, including Responsable informatique Achats et Gestion Commerciale, where oversight was provided for a team comprising two interns, one contractor, and two service providers, alongside involvement in a PIM project. Additional positions at LA HALLE included Responsable informatique Achats, focusing on an internal tool for purchase forecasting, and Chef de Projets transverses, which involved creating partnerships for commerce and transitioning stores to mixed merchandise. Furthermore, as Chef de projet e-commerce, Sophie advanced marketing needs such as enhancing SEO and developing a mobile site version. Sophie's career began as an Analyste développeur informatique, engaging in application maintenance and development across various functional areas, primarily in COBOL and C#. Sophie holds a Licence in Affaires / gestion from IUP de Management Public, earned between 2000 and 2001.
Previous companies
This person is not in any teams
This person is not in any offices
Ramsay Santé
1 followers
After the acquisition of the Capio Group in 2018, Ramsay Santé has become Europe's leading private hospital and primary care companies. The group now has 36,000 employees and works with nearly 8,600 private practitioners. Present in 5 countries, France, Sweden, Norway, Denmark and Italy, the group treats more than 7 million patients per year in its 350 establishments. In hospitalization, Ramsay Santé offers almost all medical and surgical treatments in three business lines: Medicine-Surgery-Obstetrics (MCO), Follow-up and Rehabilitation Care (SSR) and Mental Health. Wherever it is present, the group participates in public health service missions and in the health network of the country, as in Sweden where the group has more than a hundred local health centres. The quality and safety of care is the group's priority in all the countries where it operates. This is why the group is today one of the references in modern medicine, especially in ambulatory surgery and enhanced recovery after surgery (ARS). The group also invests more than €200 million every year in its establishments, whether in new surgical and imaging technologies, or in the construction and modernisation of establishments. It also innovates at the service of patients with new digital tools and by developing its organisations to improve the efficiency of care.